Compare TBBK & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TBBK | HTFL |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | 2005 | N/A |
| Metric | TBBK | HTFL |
|---|---|---|
| Price | $52.75 | $31.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $69.00 | $38.20 |
| AVG Volume (30 Days) | 382.4K | ★ 949.9K |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.69 | N/A |
| EPS | ★ 1.41 | N/A |
| Revenue | ★ $141,147,000.00 | N/A |
| Revenue This Year | N/A | $27.66 |
| Revenue Next Year | $8.16 | $23.55 |
| P/E Ratio | $38.07 | ★ N/A |
| Revenue Growth | ★ 20.85 | N/A |
| 52 Week Low | $48.86 | $20.13 |
| 52 Week High | $81.65 | $41.22 |
| Indicator | TBBK | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 32.38 | 60.03 |
| Support Level | $50.85 | $28.60 |
| Resistance Level | $55.74 | $32.81 |
| Average True Range (ATR) | 1.99 | 1.61 |
| MACD | -0.93 | -0.18 |
| Stochastic Oscillator | 5.07 | 74.88 |
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.